Xeris Biopharma Holdings, Inc. along with its subsidiaries, is referenced herein as the "Company", "Xeris", "Xeris Biopharma", "we" or "our". Throughout this document, unless otherwise noted, references to Gvoke include Gvoke PFS, Gvoke HypoPen, and Gvoke Kit. Overview We are a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. We offer Recorlev for the treatment of endog...
expected 2026-11-05
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001867096-26-000016 | EDGAR | 90K words |
| 2025-03-06 | 2024-12-31 | 0001867096-25-000039 | EDGAR | — |
| 2024-03-06 | 2023-12-31 | 0001867096-24-000031 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0001867096-23-000031 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001867096-22-000040 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001867096-26-000065 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001867096-25-000159 | EDGAR | 18K words |
| 2025-08-07 | 2025-06-30 | 0001867096-25-000136 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001867096-25-000089 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001867096-24-000187 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001867096-24-000162 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001867096-24-000065 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001867096-23-000139 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001867096-23-000114 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001867096-23-000069 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001867096-22-000127 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001867096-22-000107 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001867096-26-000063 | EDGAR | — |
| 2026-07-17 | 0001867096-26-000055 | EDGAR | — |
| 2026-03-02 | 0001867096-26-000012 | EDGAR | 4K words |
| 2026-02-27 | 0001867096-26-000010 | EDGAR | — |
| 2026-01-08 | 0001867096-26-000004 | EDGAR | — |
| 2025-12-01 | 0001867096-25-000161 | EDGAR | — |
| 2025-11-06 | 0001867096-25-000156 | EDGAR | — |
| 2025-08-07 | 0001867096-25-000130 | EDGAR | — |
| 2025-06-04 | 0001867096-25-000104 | EDGAR | — |
| 2025-06-03 | 0001867096-25-000100 | EDGAR | — |
76 total filings indexed. 49 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001867096 |
| Ticker | XERS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.xerispharma.com |
| Listed | 2018-06-21 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/XERS (~200 tokens, structured JSON with cryptographic provenance)